62 results match your criteria: "Uppsala University PET-Centre[Affiliation]"

Nine healthy volunteers aged 18-28 years were recruited into this open, single-centre, two-phase trial. In phase 1, two volunteers received a single dose of 11C-zolmitriptan 2.5 mg administered as a nasal spray and then underwent positron emission tomography (PET) scanning to determine the most appropriate times for scanning in phase 2.

View Article and Find Full Text PDF

Pheochromocytomas: detection with 11C hydroxyephedrine PET.

Radiology

February 2004

Uppsala University PET Centre, Sweden and Surgery Department, University Hospital, Uppsala, Sweden.

Purpose: To evaluate the accuracy of carbon 11 (11C) hydroxyephedrine (HED) positron emission tomography (PET) in the detection of pheochromocytomas.

Materials And Methods: Nineteen patients (12 women, seven men; mean age, 53 years) suspected of having pheochromocytoma were evaluated. Patients had enlarged adrenal glands at computed tomography and either increased urinary catecholamine levels (n = 18) or normal biochemistry (n = 1).

View Article and Find Full Text PDF

PET with [11C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions.

Clin Positron Imaging

November 1999

Subfemtomole Biorecognition Project, Uppsala University PET Centre, Departments of Surgery, Medicine, and Diagnostic Radiology, University Hospital, Uppsala, Sweden

View Article and Find Full Text PDF

Whole-Body PET with [11C]-5-Hydroxytryptophan for Localization of Neuroendocrine Tumors.

Clin Positron Imaging

November 1999

Uppsala University PET Centre, Departments of Surgery, Medicine and DiagnosticRadiology, University Hospital, Uppsala, Sweden

View Article and Find Full Text PDF

The role of PET in localization of neuroendocrine and adrenocortical tumors.

Ann N Y Acad Sci

September 2002

Department of Medical Sciences, Uppsala University PET-Centre, University Hospital, S-751 85 Uppsala, Sweden.

Positron emission tomography (PET) supplies a range of labeled compounds to be used for the characterization of tumor biochemistry. Some of these have proved to be of value for clinical diagnosis, treatment follow up, and clinical research. The first routinely used PET tracer in oncology, (18)F-labeled deoxyglucose (FDG), was successfully used for diagnosis of cancer, reflecting increased expression of glucose transporter in cancerous tissue.

View Article and Find Full Text PDF

Using R-beta-[1-(11)C]hydroxybutyrate and positron emission tomography, we studied the effect of acute hyperketonemia (range 0.7-1.7 micromol/ml) on cerebral ketone body utilization in six nondiabetic subjects and six insulin-dependent diabetes mellitus (IDDM) patients with average metabolic control (HbA(1c) = 8.

View Article and Find Full Text PDF

Monoamine neurotransmission is a complicated process with interactions between individual neurotransmitter pathways, multiple receptors with different responses and a variety of feedback loops regulating neurotransmitter synthesis, release, reuptake and effect on receptors. The system is further affected by a range of enzymes with co-factors controlling synthesis and degradation of monoamines. Positron emission tomography (PET) has evolved to a very versatile tool for the in vivo imaging and characterisation of physiology and biochemistry.

View Article and Find Full Text PDF

[(11)C] Carbon monoxide in selenium-mediated synthesis of (11)C-carbamoyl compounds.

J Org Chem

May 2002

Department of Organic Chemistry, Institute of Chemistry, and Uppsala University PET Centre, Uppsala University, S-751 85 Uppsala, Sweden.

Using either amines, amino alcohols, or alcohols in selenium-mediated synthesis with [(11)C]carbon monoxide, 3 ureas, 6 carbamates, and 1 carbonate were labeled. Tetrabutylammonium fluoride ((TBA)F) was discovered to form a soluble and reactive complex with selenium and drastically increase the radiochemical yields. Of the selected carbamoyl compounds, one was a receptor ligand, one was an enzyme inhibitor, and one was a muscular relaxant pharmaceutical.

View Article and Find Full Text PDF

The effects on the binding to cholinergic and dopaminergic receptors in the brain during continuous intravenous infusion of the muscarinic cholinergic receptor agonist milameline (CI-979) were studied in the rhesus monkey by means of positron emission tomography. Binding to milameline cholinergic receptors was quantified using the muscarinic receptor antagonist [(11)C]-N-methyl-4-piperidinylbenzilate ([(11)C]NMP), and the effects on nicotine receptor binding were measured with (S)-[(11)C-methyl]nicotine. Changes in the binding of the D(2) dopamine receptor antagonist [(11)C]raclopride were measured as well.

View Article and Find Full Text PDF

1Alpha,25-dihydroxyvitamin D(3), an endogenous ligand with the highest affinity for the vitamin D receptor (VDR), was labeled with 11C for use in biological experiments. The radionuclide was incorporated via the reaction of [11C]methyllithium on a methyl ketone precursor in tetrahydrofuran at -10 degrees C. Deprotection of the labeled intermediate yielded 2.

View Article and Find Full Text PDF

PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy.

Acta Neurol Scand

June 2001

Department of Neuroscience, Neurology and Uppsala University PET Centre, University Hospital, S-751 85 Uppsala, Sweden.

Objectives: This study compares positron emission tomography (PET) using 11C-deuterium-deprenyl (DED) with PET using 18F-fluorodeoxyglucose(18F-FDG) for examining epileptogenic regions in patients with focal epilepsy.

Material And Methods: Twenty-three patients undergoing evaluation for epilepsy surgery were subjected to PET with DED. Fourteen patients had mesial temporal lobe epilepsy (TLE) and 9 patients had seizures of neocortical origin.

View Article and Find Full Text PDF

Use of positron emission tomography in analysing receptor function in vivo.

Toxicol Lett

March 2001

Uppsala University PET Centre, University Hospital, 751 85, Uppsala, Sweden.

The non-invasive radiotracer technique positron emission tomography (PET) may provide valuable information in the toxicokinetic-toxicodynamic evaluation of endogenous or toxic environmental compounds. Assessment of mechanism of action of toxins is often difficult to validate. In this respect, PET may offer advantages since it can quantify not only the distribution and kinetics of the radiolabelled toxin in the body, but also the altered rates of physiological or biochemical processes induced by the toxin.

View Article and Find Full Text PDF

Purpose: To evaluate the utility of FDG-PET in detecting primary tumors in patients with metastatic disease from unknown primary tumors.Methods: 12 patients with metastases from unknown origin after unsuccessful conventional diagnostic procedures were studied. 5 had lymph node metastases (2 axillary, 2 cervical, 1 mediastinal), 3 multiple metastases, 1 in the lung, 1 in the cava vein, 1 in the brain and 1 in adrenal glands.

View Article and Find Full Text PDF

Positron emission tomography (PET) performed with various radiolabelled compounds facilitates the study of tumor biochemistry. If the tumor uptake of an administered tracer is greater than that of surrounding normal tissue, it is also possible to localize the tumor. In initial studies, 18F-labeled deoxyglucose (FDG) was attempted to visualize the tumors, since this tracer had been successfully used in oncology, reflecting increased glucose metabolism in cancerous tissue.

View Article and Find Full Text PDF

Oligonucleotides may hybridize with high selectivity to an RNA sequence and can be used for the monitoring of gene expression or for its inhibition in experimental or therapeutic purposes. As part of the development of positron emission tomography (PET) methods, different lengths (30, 20, 12 and 6 mer) of antisense phosphorothioate oligonucleotides complementary to rat chromogranin A were labeled with [(76)Br] using a prosthetic group. The (76)Br-oligonucleotides were injected into rat's tail vein (1-2 MBq/rat), and the radioactivity distribution was analyzed after 20 h using whole body autoradiography or by measurement of organ radioactivity concentration.

View Article and Find Full Text PDF

Two high affinity and selective NK1-receptor antagonists, GR203040 and GR205171, were labelled with 11C and used in a series of experiments in rhesus monkeys. The purpose of these studies was to evaluate the brain uptake pattern and to explore the potential use of these compounds as PET ligands to characterise NK1-receptor binding. Seventeen studies were carried out with [11C]GR205171 and five experiments with [11C]GR203040, including baseline studies and studies performed after a 5 min infusion of cold compound at doses between 0.

View Article and Find Full Text PDF

Elimination of nonspecific radioactivity from [76Br]bromide in PET study with [76Br]bromodeoxyuridine.

Nucl Med Biol

October 1999

Subfemtomole Biorecognition Project at Uppsala University PET Centre, University Hospital, Sweden.

[76Br]Bromodeoxyuridine ([76Br]BrdU) might allow a determination of proliferation in vivo using positron emission tomography (PET), but only with consideration of organ nonspecific radioactivity constituted by [76Br]bromide. A first study assessed the potential of diuretics to eliminate [76Br]bromide. [76Br]Bromide was injected in the vein of rats and different diuretic combinations were given.

View Article and Find Full Text PDF

6-diazo-5-oxo-L-norleucine (DON) exerts a growth inhibitory effect selectively on the neuroendocrine tumour cell line BON and is proposed as an antitumour drug. The mechanism behind this has not yet been clarified. In the present study, transmission electron microscopy was used for the assessment of changes in cellular organelles.

View Article and Find Full Text PDF

Some examples of recent development of the synthesis of compounds labelled with short-lived beta(+)-emitting radionuclides will be discussed with an emphasis on the importance of time in selecting a synthetic strategy. Furthermore the use of such labelled compounds to monitor certain processes in areas within the field of analytical chemistry and in various applications in drug development will be presented.

View Article and Find Full Text PDF

Objective: This study used positron emission tomography (PET) to investigate the deposition and disposition of zanamivir administered as a nasal spray.

Design: This was an open-label single-dose study in healthy volunteers.

Study Participants: Six healthy male volunteers, aged 19 to 33 years (mean age 25 years) with a bodyweight of 65 to 94 kg (mean bodyweight 76 kg), took part in the study.

View Article and Find Full Text PDF

A multivariate approach to registration of dissimilar tomographic images.

Eur J Nucl Med

July 1999

Uppsala University PET Centre, Uppsala University, Uppsala, Sweden.

We devised a method to allow for retrospective registration of tomographic images with very different information content, the main emphasis being on sets of positron emission tomography images obtained with different tracers. A multivariate cost-function based on information theory was used as an index of "goodness-of-alignment". The cost-function makes no assumptions regarding the form of the relationship between the two image sets, and is hence very general.

View Article and Find Full Text PDF

The effects of apomorphine on the striatal L-[11C]DOPA influx rate was examined in anaesthetized Rhesus monkeys using positron emission tomography (PET). In comparison with baseline conditions, the addition of a continuous infusion of apomorphine produced decreases in the striatal L-[11C]DOPA influx rate in all the monkeys examined. The effect of apomorphine infusion also showed a dose-dependent trend.

View Article and Find Full Text PDF